Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Allergy|January 1, 1993
Comparison of sputum-ECP levels in bronchial asthma and chronic bronchitisJ C Virchow, C Kroegel, U Hage, et al.
Arzneimittel-Forschung|July 1, 1991
[The action profile of D,L-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals]E Holm, U Staedt, J Heep, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 1995
T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthmaJ C Virchow, C Walker, D Hafner, et al.
Clinical and Experimental Immunology|January 10, 2003
Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulationH Höhn, M Jülch, H Pilch, et al.
Immunology|November 28, 2001
Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+ T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion patternH Höhn, C Kortsik, K Nilges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesotheliomaC Manegold, J Symanowski, U Gatzemeier, et al.
Scandinavian Journal of Immunology|April 21, 2007
MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosisH Höhn, C Kortsik, I Zehbe, et al.
Genes and Immunity|April 13, 2007
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosisF F Weichold, S Mueller, C Kortsik, et al.
Virchows Archiv : an International Journal of Pathology|June 1, 1996
Early detection of metastasis by alterations in the cellular immune system in the murine liver and bloodN Freudenberg, P Rahner, C Darda, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2014
Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancerD F Heigener, K M Deppermann, J V Pawel, et al.
Pageof 3